Neonatal exposure of TCR BV8S2 transgenic mice to recombinant TCR BV8S2 results in reduced T cell proliferation and elevated antibody response to BV8S2, and increased severity of EAE

Journal of Neuroscience Research

Volumn 52, Issue 6, 1998, Pages 750-756

  Siklodi, Botond ^a,b,c   Jacobs, Raymond ^b   Vandenbark, Arthur A ^b,c   Offner, Halina ^b,c  

^a TEVA PHARMACEUTICALS   (Israel)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

EAE; Neonatal tolerance; Transgenics

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENCEPHALOMYELITIS; GENETIC RECOMBINATION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATOR GENE; SCORING SYSTEM; SEQUENCE HOMOLOGY; T LYMPHOCYTE RECEPTOR GENE;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLUTATHIONE TRANSFERASE; IMMUNE TOLERANCE; MALE; MICE; MICE, TRANSGENIC; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS; REFERENCE VALUES; T-LYMPHOCYTES; TRANSGENES;

EID: 0032526922     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980615)52:6<750::AID-JNR14>3.0.CO;2-2     Document Type: Article

References (23)

1. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith D, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L (1988): Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventions. Cell 54:263-273.
2. Buenafe AC, Tsu RC, Bebo B Jr., Vandenbark AA, Offner H (1997): Myelin basic protein-specific and TCR BV8S2-specific T-cell lines from TCR BV8S2 transgenic mice utilize the same Vα and Vβ genes: Specificity associated with the VaCDR3-Jα region. J Neurosci Res 47:489-499.
3. De Wit D, Van Mechelen M, Ryelandt M, Figueiredo AC, Abramowicz D, Goldman M, Bazin H, Urbain J, Leo O (1992): The injection of deaggregated gamma globulin in adult mice induces antigenspecific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med 175:9-14.
4. Durle FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993): Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330.
5. Falcone M, Bloom BR (1997): A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 185:901-907.
6. Forsthuber T, Yip HC, Lehmann PV (1996): Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728-1730.
7. Gaur A, Haspel R, Mayer JP, Fathman CG (1993): Requirement for CD8+ T cells in T cell receptor peptide-induced clonal unresponsiveness. Science 259:91-94.
8. Gilbert KM, Rothermel AL, Ernst DN, Hobbs MV, Weigle WO (1992): Ability of tolerized Th1 and Th2 clones to stimulate B cell activation and cell cycle progression. Cell Immunol 142:1-15.
9. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993): Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560.
10. Hashim GA, Offner H, Wang RY, Shukla K, Carvalho E, Morrison WJ, Vandenbark AA (1992): Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-BV8S2 chain. J Immunol 149:2803-2809.
11. Heber-Katz E, Acha-Orbea H (1989): The V-region hypothesis: Evidence from autoimmune encephalomyelitis. Immunol Today 10:164-166.
12. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989): Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668-670.
13. + T cells in recovery from antigen-induced autoimmune disease. J Exp Med 178:909-916.
14. Kumar V, Stellrecht K, Sercarz E (1996): Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J Exp Med 184:1609-1617.
15. Martin R, McFarland HF (1995): Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121-182.
16. Offner H, Hashim G, Vandenbark AA (1991): T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430-432.
17. Offner H, Adlard K, Bebo Jr. BF, Schuster J, Burrows GG, Buenate AC, Vandenbark AA (submitted): Vaccination with BV8S2 protein amplifies TCR specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice. J Immunol.
18. Peterson JD, Karpus WJ, Clatch RJ, Miller SD (1993): Split tolerance of Th I and Th2 cells intolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 23:46-55.
19. Singh RR, Hahn BH, Sercarz EE (1996): Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: Implications for antibody vs. T cell mediated autoimmunity. J Exp Med 183:1613-1621.
20. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L (1988): Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592.
21. Vainiene M, Burrows GG, Ariail K, Robey I, Vandenbark AA, Offner H (1996): Neonatal injection of Lewis rats with recombinant BV8S2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis. J Neurosci Res 45:475-486.
22. Vandenbark AA, Hashim GA, Offner H (1989): Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544.
23. Vandenbark AA, Hashim GA, Offner H (1995): Idiotypic regulation directed at T-cell receptor determinants. Chem lmmunol 60:100-125.